Author:
Hernández-Camacho Juan Diego
Publisher
Springer International Publishing
Reference76 articles.
1. Abdul-Ghani MA, DeFronzo RA (2008) Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr Diab Rep 8(3):173–178.
https://doi.org/10.1007/s11892-008-0030-1
2. Alam MA, Rahman MM (2014) Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord 13:60.
https://doi.org/10.1186/2251-6581-13-60
3. Babic D, Maslov B, Martinac M, Nikolic K, Uzun S, Kozumplik O (2010) Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder. Psychiatr Danub 22(1):75–78
4. Buchmann N, Spira D, Konig M, Demuth I, Steinhagen-Thiessen E (2019) Frailty and the metabolic syndrome – results of the Berlin Aging Study II (BASE-II). J Frailty Aging 8(4):169–175.
https://doi.org/10.14283/jfa.2019.15
5. Bugger H, Abel ED (2008) Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114(3):195–210.
https://doi.org/10.1042/CS20070166